Capital International Investors 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:32 pm Purchase |
2024-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital International Investors | 8,896,223 9.300% |
2,532,633 (+39.80%) |
Filing |
| 2024-11-13 10:27 am Purchase |
2024-11-14 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital International Investors | 6,363,590 6.700% |
1,622,105 (+34.21%) |
Filing |
| 2024-02-09 6:05 pm Purchase |
2024-02-07 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital International Investors | 4,741,485 5.100% |
4,741,485 (New Position) |
Filing |